Ingredient Guide
Acetylarginyltryptophyl Diphenylglycine
Also known as: Acetylarginyltryptophyl Diphenylglycine, SNAP-8 Component, Leuphasyl-adjacent peptide
All skin types
What It Is
A synthetic peptide that acts on glutamate receptors to modulate muscle contraction signaling at the neuromuscular junction. Used as part of advanced multi-peptide anti-aging formulas.
What It Does
Reduces muscle contraction signaling through a glutamate receptor pathway — complementary to the SNARE (Argireline) and opioid receptor (Pentapeptide-18) mechanisms used by other expression-reducing peptides.
Best For
Expression linesMulti-pathway anti-aging peptide approach
Benefits
- Third distinct pathway for expression line targeting — complements Argireline and Pentapeptide-18
- Glutamate receptor modulation is a different mechanism from competing expression-reducing peptides
When to Be Careful
- Independent clinical data is limited compared to the original Matrixyl or Argireline peptides
- Primarily used in sophisticated multi-peptide complexes rather than as a standalone active
Commonly Found In
Advanced multi-peptide anti-aging serums
FAQs About Acetylarginyltryptophyl Diphenylglycine
What does acetylarginyltryptophyl diphenylglycine do?
It targets glutamate receptors to modulate neuromuscular signaling, reducing the muscle contractions that create expression lines. It works through a different pathway from Argireline (SNARE) and Pentapeptide-18 (opioid receptor), providing a broader multi-mechanism approach in multi-peptide formulas.